Buying time : management of mild cognitive impairment and early dementiaSALLOWAY, Stephen.International psychogeriatrics. 2006, Vol 18, issn 1041-6102, S17-S23, SUP1Conference Paper

Cholinergic treatment across the spectrum: therapeutic trends in mild to severe dementiaSALLOWAY, Stephen.International psychogeriatrics. 2006, Vol 18, issn 1041-6102, 33 p., SUP1Conference Proceedings

Emerging biology of the cholinergic system across the spectrum of Alzheimer's diseaseNORDBERG, Agneta.International psychogeriatrics. 2006, Vol 18, issn 1041-6102, S3-S16, SUP1Conference Paper

Severe Alzheimer's disease : benefits of donepezil therapyWINBLAD, Benqt.International psychogeriatrics. 2006, Vol 18, issn 1041-6102, S25-S31, SUP1Conference Paper

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's DiseaseFRAKEY, Laura L; SALLOWAY, Stephen; BUELOW, Melissa et al.The Journal of clinical psychiatry. 2012, Vol 73, Num 6, pp 796-801, issn 0160-6689, 6 p.Article

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseBATEMAN, Randall J; CHENGJIE XIONG; HOLTZMAN, David M et al.The New England journal of medicine. 2012, Vol 367, Num 9, pp 795-804, issn 0028-4793, 10 p.Article

Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer diseaseRYMER, Susan; SALLOWAY, Stephen; NORTON, Lauren et al.Alzheimer disease and associated disorders. 2002, Vol 16, Num 4, pp 248-253, issn 0893-0341, 6 p.Article

Cerebral Cortical Arteriolar Angiopathy, Vascular Beta-Amyloid, Smooth Muscle Actin, Braak Stage, and APOE GenotypeSTOPA, Edward G; BUTALA, Parag; SALLOWAY, Stephen et al.Stroke (1970). 2008, Vol 39, Num 3, pp 814-821, issn 0039-2499, 8 p.Article

Perspectives on depression, mild cognitive impairment, and cognitive declineSTEFFENS, David C; OTEY, Emeline; LOPEZ, Oscar L et al.Archives of general psychiatry. 2006, Vol 63, Num 2, pp 130-138, issn 0003-990X, 9 p.Article

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer DiseaseCORIC, Vladimir; VAN DYCK, Christopher H; COLBY, Susan et al.Archives of neurology (Chicago). 2012, Vol 69, Num 11, pp 1430-1440, issn 0003-9942, 11 p.Article

Amyloid-β Associated Cortical Thinning in Clinically Normal ElderlyBECKER, J. Alex; HEDDEN, Trey; MARKS, Donald et al.Annals of neurology. 2011, Vol 69, Num 6, pp 1032-1042, issn 0364-5134, 11 p.Article

Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled Clinical trial. CommentaryBLACK, Sandra; ROMAN, Gustavo C; GELDMACHER, David S et al.Stroke (1970). 2003, Vol 34, Num 10, pp 2323-2332, issn 0039-2499, 10 p.Article

Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia: Differential Effects by Hippocampal SizeROMAN, Gustavo C; SALLOWAY, Stephen; BLACK, Sandra E et al.Stroke (1970). 2010, Vol 41, Num 6, pp 1213-1221, issn 0039-2499, 9 p.Article

The long-term efficacy and tolerability of donepezil in patients with vascular dementiaWILKINSON, David; ROMAN, Gustavo; SALLOWAY, Stephen et al.International journal of geriatric psychiatry. 2010, Vol 25, Num 3, pp 305-313, issn 0885-6230, 9 p.Article

Assessing motor and cognitive regulation in AD, MCI, and controls using the Behavioral Dyscontrol ScaleBELANGER, Heather G; WILDER-WILLIS, Kelly; MALLOY, Paul et al.Archives of clinical neuropsychology. 2005, Vol 20, Num 2, pp 183-189, issn 0887-6177, 7 p.Article

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseSALLOWAY, Stephen; SPERLING, Reisa; REICHERT, Marcel et al.The New England journal of medicine. 2014, Vol 370, Num 4, pp 322-333, issn 0028-4793, 12 p.Article

Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer DiseaseBLENNOW, Kaj; ZETTERBERG, Henrik; RINNE, Juha O et al.Archives of neurology (Chicago). 2012, Vol 69, Num 8, pp 1002-1010, issn 0003-9942, 9 p.Article

Effectiveness and Tolerability of High-Dose (23 mg/d) Versus Standard-Dose (10 mg/d) Donepezil in Moderate to Severe Alzheimer's Disease: A 24-Week, Randomized, Double-Blind StudyFARLOW, Martin R; SALLOWAY, Stephen; TARIOT, Pierre N et al.Clinical therapeutics. 2010, Vol 32, Num 7, pp 1234-1251, issn 0149-2918, 18 p.Article

Donepezil in vascular dementia : Combined analysis of two large-scale clinical trialsROMAN, Gustavo C; WILKINSON, David G; DOODY, Rachelle S et al.Dementia and geriatric cognitive disorders. 2005, Vol 20, Num 6, pp 338-344, issn 1420-8008, 7 p.Article

Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorderGREENBERG, Benjamin D; MALONE, Donald A; FRIEHS, Gerhard M et al.Neuropsychopharmacology (New York, NY). 2006, Vol 31, Num 11, pp 2384-2393, issn 0893-133X, 10 p.Article

Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive DeclineGRUNDMAN, Michael; PONTECORVO, Michael J; AGBULOS, Abigail et al.Alzheimer disease and associated disorders. 2013, Vol 27, Num 1, pp 4-15, issn 0893-0341, 12 p.Article

Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant DepressionMALONE, Donald A; DOUGHERTY, Darin D; TYRKA, Audrey R et al.Biological psychiatry (1969). 2009, Vol 65, Num 4, pp 267-275, issn 0006-3223, 9 p.Article

The pattern of atrophy in familial Alzheimer disease: Volumetric MRI results from the DIAN studyCASH, David M; RIDGWAY, Gerard R; GHETTI, Bernardino F et al.Neurology. 2013, Vol 81, Num 16, pp 1425-1433, issn 0028-3878, 9 p.Article

Impaired default network functional connectivity in autosomal dominant Alzheimer diseaseCHHATWAL, Jasmeer P; SCHULTZ, Aaron P; MARCUS, Daniel S et al.Neurology. 2013, Vol 81, Num 8, pp 736-744, issn 0028-3878, 9 p.Article